Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology.
New answer by at Johns Hopkins School of Medicine (February 13, 2024)
Yes, if there is no other features that suggest there is another etiology for the event. Immune-related adverse events (irAEs) can present after immunotherapy is stopped for a...